BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28711141)

  • 21. Polygenic risk score trend and new variants on chromosome 1 are associated with male gout in genome-wide association study.
    Chang YS; Lin CY; Liu TY; Huang CM; Chung CC; Chen YC; Tsai FJ; Chang JG; Chang SJ
    Arthritis Res Ther; 2022 Oct; 24(1):229. PubMed ID: 36221101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-specific association between ABCG2 variants and tophaceous disease in people with gout.
    He W; Phipps-Green A; Stamp LK; Merriman TR; Dalbeth N
    Arthritis Res Ther; 2017 Mar; 19(1):43. PubMed ID: 28270222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Ikebuchi Y; Ito K; Kusanagi Y; Chiba T; Tadokoro S; Takada Y; Oikawa Y; Inoue H; Suzuki K; Okada R; Nishiyama J; Domoto H; Watanabe S; Fujita M; Morimoto Y; Naito M; Nishio K; Hishida A; Wakai K; Asai Y; Niwa K; Kamakura K; Nonoyama S; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Hamajima N; Shinomiya N
    Sci Transl Med; 2009 Nov; 1(5):5ra11. PubMed ID: 20368174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
    Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study.
    Chen CJ; Tseng CC; Yen JH; Chang JG; Chou WC; Chu HW; Chang SJ; Liao WT
    Sci Rep; 2018 Feb; 8(1):3137. PubMed ID: 29453348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetic basis of gout.
    Merriman TR; Choi HK; Dalbeth N
    Rheum Dis Clin North Am; 2014 May; 40(2):279-90. PubMed ID: 24703347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout.
    Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; He H; Ji H; Jin L; Zou H; Wang J
    Hereditas; 2020 Jan; 157(1):2. PubMed ID: 32000861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Characterization of Clinically-Relevant Rare Variants in
    Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
    Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
    Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
    Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout.
    Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
    Liu J; Yang W; Li Y; Wei Z; Dan X
    BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic background of uric acid metabolism in a patient with severe chronic tophaceous gout.
    Petru L; Pavelcova K; Sebesta I; Stiburkova B
    Clin Chim Acta; 2016 Sep; 460():46-9. PubMed ID: 27288985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.
    Nakayama A; Matsuo H; Takada T; Ichida K; Nakamura T; Ikebuchi Y; Ito K; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1091-7. PubMed ID: 22132962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
    Hurba O; Mancikova A; Krylov V; Pavlikova M; Pavelka K; Stibůrková B
    PLoS One; 2014; 9(9):e107902. PubMed ID: 25268603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes.
    Giri AK; Banerjee P; Chakraborty S; Kauser Y; Undru A; Roy S; Parekatt V; Ghosh S; Tandon N; Bharadwaj D
    Sci Rep; 2016 Feb; 6():21440. PubMed ID: 26902266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2.
    Toyoda Y; Pavelcová K; Klein M; Suzuki H; Takada T; Stiburkova B
    Arthritis Res Ther; 2019 Oct; 21(1):219. PubMed ID: 31661014
    [No Abstract]   [Full Text] [Related]  

  • 38. ABCG2: the molecular mechanisms of urate secretion and gout.
    Woodward OM
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F485-8. PubMed ID: 26136557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge.
    Dalbeth N; House ME; Gamble GD; Pool B; Horne A; Purvis L; Stewart A; Merriman M; Cadzow M; Phipps-Green A; Merriman TR
    Arthritis Res Ther; 2014 Jan; 16(1):R34. PubMed ID: 24476385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of four genetic loci with uric acid levels and reduced renal function: the J-SHIPP Suita study.
    Tabara Y; Kohara K; Kawamoto R; Hiura Y; Nishimura K; Morisaki T; Kokubo Y; Okamura T; Tomoike H; Iwai N; Miki T
    Am J Nephrol; 2010; 32(3):279-286. PubMed ID: 20714133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.